ABSTRACT
Background: Coronavirus disease [severe acute respiratory syndrome coronavirus disease 19 (SARS COVID-19)] has emerged as one of the most challenging diseases of recent decades. After the pandemic outbreak, our knowledge of the virus has expanded and developed, but we face a new wave of atypical complications that require special attention. In addition to the acute complications of COVID-19 infection, late complications of the disease are taking an increasingly important part in the management of affected patients, which are grouped under the collective term "Long COVID". In this work, we present our therapy strategy in three cases of pulmonary cavity as a late complication after COVID-19, as well as perform a literature review of published articles in this matter. Case Description: This study includes 3 cases of pulmonary cavities as a late COVID complication. Among them only one patient was vaccinated. The mean duration between the occurrence of Long COVID and SARS COVID-19 disease was 4 weeks in our patients. All patients underwent adequate medical therapy after Long COVID. However, due to the disease progression and significant elevated infections parameters, all patients underwent surgical therapy. One patient underwent uniportal video-assisted thoracoscopic surgery (VATS) lobectomy and decortication of the empyema, whereas we performed thoracotomy for other patients. All patients treated successfully and discharged shortly after the operation. Our literature review provides a total of 12 publications with only 50 patients. No patients received vaccination. The mean interval time between acute infection and the appearance of pulmonary cavities was about 4 weeks. The results showed that most patients were treated with conservative therapies. Only two patients were treated using invasive therapies. Both patients were successfully treated and recovered from the procedures. Conclusions: This group of late complications COVID patients requires individualized treatment strategy. In the case of an underlying pulmonary cavities, depending on the findings, despite increased perioperative risks, very good results can be achieved by presentation to a specialized and experienced thoracic surgery center.
ABSTRACT
Carcinoembryonic antigen (CEA) is a tumor marker for detecting recurrences of adenocarcinomas such as colon cancer. In lung adenocarcinoma, CEA elevation can be found in both serum and malignant pleural effusion. However, CEA elevation in cytologically negative pleural effusion in the presence of adenocarcinoma without pleural infiltration has not been described. We here present the case of an 82-year-old man with incidental early stage adenocarcinoma of the right upper lobe showing CEA elevation in pleural fluid and serum despite negative cytological findings. Due to limited lung reserve the tumor was removed by wide wedge resection, but the visceral pleura was not affected and infiltration of the parietal pleura was ruled out by pleural biopsies. Serum and pleural CEA levels declined postoperatively as measured at 1 and 2 months follow-up. This case shows CEA elevation in serum and pleural fluid in early stage lung adenocarcinoma with negative cytology and no sign of pleural infiltration. Previous research revealed that CEA level in pleural effusion correlates to serum CEA and is significantly higher in adenocarcinoma of the lung than in other lung cancer entities. Firstly, this case suggests that determination of CEA levels can increase the diagnostic sensitivity in cases with cytologically negative pleural effusion suspicious of malignant origin and secondly, it contributes valuable information to the decision whether follow-up of pulmonary nodules or continuative diagnostics such as video-assisted thoracoscopic surgery (VATS) wedge resection is indicated.
ABSTRACT
Standard recommendation for therapy of benign mediastinal cysts is surgery. Endobronchial ultrasound fine needle aspiration (EBUS-FNA) has been used by some researchers as a diagnostic tool. This approach may be associated with severe life-threatening complications. We describe a case of life-threatening purulent pericardial effusion with tamponade by infection of a bronchogenic cyst after EBUS-FNA.
Subject(s)
Biopsy, Fine-Needle/adverse effects , Bronchogenic Cyst/pathology , Image-Guided Biopsy/adverse effects , Pneumonia, Bacterial/etiology , Streptococcal Infections/etiology , Adult , Anti-Bacterial Agents/therapeutic use , Biopsy, Fine-Needle/methods , Bronchogenic Cyst/diagnostic imaging , Bronchogenic Cyst/surgery , Cardiac Tamponade/etiology , Cardiac Tamponade/microbiology , Cardiac Tamponade/surgery , Drainage/methods , Female , Follow-Up Studies , Humans , Image-Guided Biopsy/methods , Pericardial Effusion/etiology , Pericardial Effusion/microbiology , Pericardial Effusion/surgery , Pneumonia, Bacterial/physiopathology , Pneumonia, Bacterial/surgery , Risk Assessment , Severity of Illness Index , Streptococcal Infections/diagnostic imaging , Streptococcal Infections/surgery , Thoracotomy/methods , Tomography, X-Ray Computed/methods , Treatment Outcome , UltrasonographyABSTRACT
Very late valvular and/or coronary artery diseases after mediastinal radiation are rare but well known. Late radiation induced osteonecrosis of the sternoclavicular joint is very rare. The combination of both or all three diseases has not yet been described to the best of our knowledge. We report on such a case with particular respect to the difficult discrimination of aseptic and septic bone destruction.